Steward Partners Investment Advisory’s Immunomedics Inc IMMU Stock Holding History

Steward Partners Investment Advisory’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,600	Closed	-$35K	–	2808
2020 Q1	$35K	Sell	2,600 -1,000	-28%	-$16.8K	﹤0.01%	1401
2019 Q4	$76K	Hold	3,600	–	–	﹤0.01%	1234
2019 Q3	$47K	Hold	3,600	–	–	﹤0.01%	1387
2019 Q2	$49K	Buy	+3,600	New	+$54.2K	﹤0.01%	1347
2018 Q4	–	Sell	-3,600	Closed	-$75K	–	2457
2018 Q3	$75K	Buy	3,600 +1,800	+100%	+$42.6K	﹤0.01%	1034
2018 Q2	$43K	Hold	1,800	–	–	﹤0.01%	1163
2018 Q1	$26K	Hold	1,800	–	–	﹤0.01%	1243
2017 Q4	$29K	Hold	1,800	–	–	﹤0.01%	1007
2017 Q3	$25K	Sell	1,800 -200	-10%	-$1.99K	﹤0.01%	883
2017 Q2	$17K	Sell	2,000 -2,000	-50%	-$14K	﹤0.01%	922
2017 Q1	$25K	Buy	+4,000	New	+$20.3K	﹤0.01%	705

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Steward Partners Investment Advisory's IMMU Position: Q2 2020 in Review

Steward Partners Investment Advisory sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 2,600 shares — an estimated $35K sold.

Steward Partners Investment Advisory first reported a position in IMMU in Q1 2017 and held it in 11 quarters. The position peaked at $76K in Q4 2019. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

Steward Partners Investment Advisory reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
Steward Partners Investment Advisory sold 2,600 Immunomedics Inc shares in Q2 2020, an estimated $35K.
Steward Partners Investment Advisory first reported a position in Immunomedics Inc in Q1 2017 and held it in 11 quarters.
Steward Partners Investment Advisory's Immunomedics Inc position peaked at $76K in Q4 2019.
313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2020, filed 6 Aug 2020.